ArTara Therapeutics, Inc. Gains 70.06%

ArTara Therapeutics, Inc. (TARA:NASDAQ) rocketted at $6.02, representing a gain of 70.1%. On Thu, Dec 05, 2024, TARA:NASDAQ touched a New 2-Week High of $6.02. The stock appeared on our News Catalysts scanner on Thu, Dec 05, 2024 at 10:15 AM in the 'BIOTECH' category. From Thu, Nov 21, 2024, the stock recorded 77.78% Up Days and 60.00% Green Days

The stock spiked on Thu, Dec 05, 2024 at $10.48 with a volume of 110M+.

About ArTara Therapeutics, Inc. (TARA:NASDAQ)

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).